Hurst Hall is a Cardiology physician affiliated with The University of Texas Southwestern Medical Center. OpenAlex indexes 23 publications with 282 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABIOMEDProgram year20252 payments
- ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)Program year20252 payments
- Teleflex LLCProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
83.7%Statin22.2%Atorvastatin Calcium82%Rosuvastatin Calcium18%Part D≥46 patientsBeta blocker16.8%Metoprolol Succinate48%Carvedilol35%Metoprolol Tartrate17%Part D<11 patients+ 8 more classes in this area
Blood & clotting
12.4%P2Y12 inhibitor6.6%Clopidogrel100%Part D≥23 patientsFactor Xa inhibitor4.2%Eliquis100%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
3.9%SGLT2 inhibitor3.9%Jardiance100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- 26-A-10089-ACC ANTIPLATELET THERAPY FOR CONSERVATIVELY MANAGED SPONTANEOUS CORONARY ARTERY DISSECTION
Journal of the American College of Cardiology
2026 - Automated SCAI Staging as a Novel Decision Aid in Cardiogenic Shock Management
Journal of Cardiac Failure
2026 - Relation Between the Incidence of In-Hospital Cardiac Arrest and Survival in Older Patients
Journal of the American College of Cardiology
2025 - Temporal Trends, Patient Characteristics, and Outcomes of Type 2 Versus Type 1 Myocardial Infarction Among Medicare Beneficiaries
Circulation Cardiovascular Quality and Outcomes
2025 - ASSESSING ANTICOAGULATION STRATEGIES DURING INTRA-AORTIC BALLOON PUMP COUNTERPULSATION THERAPY
Journal of the American College of Cardiology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Robert Toto, MD
The University of Texas Southwestern Medical Center
Abhimanyu Garg, MD
The University of Texas Southwestern Medical Center
Graham Emslie, MD
The University of Texas Southwestern Medical Center
Jing Chen, MD
The University of Texas Southwestern Medical Center
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Martin Leon, MD
Columbia University Irving Medical Center
Scott Solomon, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”